Lidocaine 0.05 MG/MG Topical Ointment — RxCUI 1543069
RxNorm drug concept · Semantic clinical drug
RxCUI 1543069
Semantic clinical drug · SCD
● Current RxNorm concept 64 FDA products
98 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1543069
Official nameLidocaine 0.05 MG/MG Topical Ointment
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslidocaine 5 % Topical Ointment
FDA products mapped64
Package NDCs mapped98
Reported Medicaid activity (SDUD)247,271 prescriptions · 49 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Lidocaine Transdermal Patch: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It relieves nerve pain from post-herpetic neuralgia, the lingering pain that can follow shingles. It is used in adults. It numbs the pain signals in the skin under the patch.
- Usually up to 12 hours in a 24-hour period, then 12 hours off. Put it on intact skin over the most painful spot. Do not use more patches than prescribed.
- No. Heat can increase how much lidocaine gets absorbed. With Ztlido, you can apply a patch after brief heat, but never put a heating pad or electric blanket directly on it.
- For Ztlido, light exercise and short water exposure, like a 10-minute shower, are okay. Gently pat it dry rather than rubbing. If the edges lift, press them down.
🕸️ Concept Web — How Lidocaine 0.05 MG/MG Topical Ointment Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Lidocaine 0.05 MG/MG Topical Ointment
RxCUI 1543069 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Lidocaine
6387IN
-
Lidocaine
-
Dose forms 4
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Lidocaine Topical Ointment
372598SCDF -
Lidocaine Topical Product
1164666SCDG -
Topical Ointment
316985DF -
Topical Product
1151122DFG
-
Lidocaine Topical Ointment
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Lidocaine 0.05 MG/MG
332430SCDC
-
Lidocaine 0.05 MG/MG
Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Lidocaine 0.05 MG/MG
SCDC · 332430 -
Lidocaine Topical Ointment
SCDF · 372598 -
Lidocaine Topical Product
SCDG · 1164666
📦 FDA Products & Package NDCs
64 products · 98 package NDCs
98 package NDCs map to RxCUI 1543069 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00168-0204-37 | 1 TUBE in 1 CARTON (0168-0204-37) / 35.44 g in 1 TUBE | Lidocaine | Fougera Pharmaceuticals, LLC | 1972-06-30 |
| 00362-0221-10 | 50 g in 1 JAR (0362-0221-10) | Lidocaine | Septodont, Inc. | 2015-05-20 |
| 16714-0878-01 | 1 TUBE in 1 CARTON (16714-878-01) / 35.44 g in 1 TUBE | lidocaine | Northstar Rx LLC | 2018-12-31 |
| 16714-0878-02 | 50 g in 1 JAR (16714-878-02) | lidocaine | Northstar Rx LLC | 2018-12-31 |
| 17856-3008-01 | 120 SYRINGE in 1 BOX, UNIT-DOSE (17856-3008-1) / 1 g in 1 S... | Lidocaine | ATLANTIC BIOLOGICALS CORP. | 2021-01-26 |
| 33342-0405-30 | 1 TUBE in 1 CARTON (33342-405-30) / 30 g in 1 TUBE | Lidocaine | Macleods Pharmaceuticals Limited | 2021-03-01 |
| 33342-0405-35 | 1 TUBE in 1 CARTON (33342-405-35) / 35.44 g in 1 TUBE | Lidocaine | Macleods Pharmaceuticals Limited | 2021-03-01 |
| 33342-0405-44 | 50 g in 1 JAR (33342-405-44) | Lidocaine | Macleods Pharmaceuticals Limited | 2025-11-18 |
| 33342-0405-50 | 1 TUBE in 1 CARTON (33342-405-50) / 50 g in 1 TUBE | Lidocaine | Macleods Pharmaceuticals Limited | 2021-03-01 |
| 46708-0424-30 | 1 TUBE in 1 CARTON (46708-424-30) / 30 g in 1 TUBE | LIDOCAINE | Alembic Pharmaceuticals Limited | 2025-02-11 |
| 46708-0424-35 | 1 TUBE in 1 CARTON (46708-424-35) / 35.44 g in 1 TUBE | LIDOCAINE | Alembic Pharmaceuticals Limited | 2025-02-11 |
| 46708-0424-50 | 50 g in 1 JAR (46708-424-50) | LIDOCAINE | Alembic Pharmaceuticals Limited | 2025-02-11 |
| 50090-7922-00 | 1 TUBE in 1 CARTON (50090-7922-0) / 35.44 g in 1 TUBE | lidocaine | A-S Medication Solutions | 2026-03-04 |
| 51407-0383-35 | 1 TUBE in 1 CARTON (51407-383-35) / 35.44 g in 1 TUBE | Lidocaine | Golden State Medical Supply, Inc. | 2021-02-02 |
| 51672-3008-05 | 1 JAR in 1 CARTON (51672-3008-5) / 50 g in 1 JAR | Lidocaine | Sun Pharmaceutical Industries, Inc. | 1981-08-17 |
| 51672-3020-02 | 1 TUBE in 1 CARTON (51672-3020-2) / 30 g in 1 TUBE | Lidocaine | Sun Pharmaceutical Industries, Inc. | 2013-03-25 |
| 51672-3020-09 | 1 TUBE in 1 CARTON (51672-3020-9) / 35.44 g in 1 TUBE | Lidocaine | Sun Pharmaceutical Industries, Inc. | 2013-03-25 |
| 59651-0591-30 | 1 TUBE in 1 CARTON (59651-591-30) / 30 g in 1 TUBE | Lidocaine | Aurobindo Pharma Limited | 2024-06-18 |
| 59651-0591-35 | 1 TUBE in 1 CARTON (59651-591-35) / 35.44 g in 1 TUBE | Lidocaine | Aurobindo Pharma Limited | 2024-06-18 |
| 59651-0591-50 | 50 g in 1 JAR (59651-591-50) | Lidocaine | Aurobindo Pharma Limited | 2024-06-18 |
| 62332-0424-30 | 1 TUBE in 1 CARTON (62332-424-30) / 30 g in 1 TUBE | LIDOCAINE | Alembic Pharmaceuticals Inc. | 2018-11-30 |
| 62332-0424-35 | 1 TUBE in 1 CARTON (62332-424-35) / 35.44 g in 1 TUBE | LIDOCAINE | Alembic Pharmaceuticals Inc. | 2018-11-30 |
| 62332-0424-50 | 50 g in 1 JAR (62332-424-50) | LIDOCAINE | Alembic Pharmaceuticals Inc. | 2018-11-30 |
| 63629-2503-01 | 1 TUBE in 1 CARTON (63629-2503-1) / 50 g in 1 TUBE | Lidocaine | Bryant Ranch Prepack | 2021-03-09 |
| 63629-2504-01 | 1 TUBE in 1 CARTON (63629-2504-1) / 35.44 g in 1 TUBE | Lidocaine | Bryant Ranch Prepack | 2021-03-09 |
| 63629-8848-01 | 1 TUBE in 1 CARTON (63629-8848-1) / 35.44 g in 1 TUBE | Lidocaine | Bryant Ranch Prepack | 2021-09-20 |
| 64380-0789-23 | 30 g in 1 TUBE (64380-789-23) | Lidocaine | Strides Pharma Science Limited | 2019-01-01 |
| 64380-0789-32 | 35.44 g in 1 TUBE (64380-789-32) | Lidocaine | Strides Pharma Science Limited | 2019-01-01 |
| 64380-0789-33 | 50 g in 1 JAR (64380-789-33) | Lidocaine | Strides Pharma Science Limited | 2019-01-01 |
| 65162-0918-30 | 1 TUBE in 1 CARTON (65162-918-30) / 30 g in 1 TUBE | Lidocaine | Amneal Pharmaceuticals LLC | 2015-08-10 |
| 65162-0918-38 | 1 TUBE in 1 CARTON (65162-918-38) / 35.44 g in 1 TUBE | Lidocaine | Amneal Pharmaceuticals LLC | 2015-08-10 |
| 65162-0918-41 | 150 g in 1 JAR (65162-918-41) | Lidocaine | Amneal Pharmaceuticals LLC | 2015-08-10 |
| 65162-0918-45 | 250 g in 1 JAR (65162-918-45) | Lidocaine | Amneal Pharmaceuticals LLC | 2015-08-10 |
| 65162-0918-53 | 50 g in 1 JAR (65162-918-53) | Lidocaine | Amneal Pharmaceuticals LLC | 2015-08-10 |
| 68071-3792-05 | 1 JAR in 1 CARTON (68071-3792-5) / 50 g in 1 JAR | Lidocaine | NuCare Pharmaceuticals, Inc. | 2025-02-13 |
| 68462-0418-20 | 1 TUBE in 1 CARTON (68462-418-20) / 35.44 g in 1 TUBE | lidocaine | Glenmark Pharmaceuticals Inc., USA | 2016-07-01 |
| 68462-0418-27 | 50 g in 1 JAR (68462-418-27) | lidocaine | Glenmark Pharmaceuticals Inc., USA | 2016-07-01 |
| 68788-4050-05 | 1 JAR in 1 CARTON (68788-4050-5) / 50 g in 1 JAR | Lidocaine | Preferred Pharmaceuticals Inc. | 2025-11-17 |
| 68788-7376-03 | 1 TUBE in 1 CARTON (68788-7376-3) / 35.44 g in 1 TUBE | Lidocaine | Preferred Pharmaceuticals Inc. | 2016-08-23 |
| 68788-7376-05 | 50 g in 1 JAR (68788-7376-5) | Lidocaine | Preferred Pharmaceuticals Inc. | 2016-08-23 |
| 68788-7766-05 | 50 g in 1 JAR (68788-7766-5) | LIDOCAINE | Preferred Pharmaceuticals, Inc. | 2020-08-03 |
| 68788-8396-05 | 50 g in 1 JAR (68788-8396-5) | lidocaine | Preferred Pharmaceuticals Inc. | 2023-03-01 |
| 70518-3746-00 | 1 TUBE in 1 CARTON (70518-3746-0) / 50 g in 1 TUBE | Lidocaine | REMEDYREPACK INC. | 2023-06-05 |
| 70518-3902-00 | 50 g in 1 JAR (70518-3902-0) | lidocaine | REMEDYREPACK INC. | 2023-10-20 |
| 70518-3972-00 | 50 g in 1 TUBE (70518-3972-0) | lidocaine | REMEDYREPACK INC. | 2023-12-28 |
| 70518-4192-00 | 50 g in 1 JAR (70518-4192-0) | LIDOCAINE | REMEDYREPACK INC. | 2024-09-30 |
| 70752-0113-03 | 1 TUBE in 1 CARTON (70752-113-03) / 35.44 g in 1 TUBE | Lidocaine | QUAGEN PHARMACEUTICALS LLC | 2021-04-20 |
| 70752-0113-04 | 50 g in 1 JAR (70752-113-04) | Lidocaine | QUAGEN PHARMACEUTICALS LLC | 2021-04-20 |
| 70752-0113-07 | 150 g in 1 JAR (70752-113-07) | Lidocaine | QUAGEN PHARMACEUTICALS LLC | 2021-04-20 |
| 70752-0113-13 | 250 g in 1 JAR (70752-113-13) | Lidocaine | QUAGEN PHARMACEUTICALS LLC | 2021-04-20 |
Observed labelers:
Proficient Rx LP (15) ·
Bryant Ranch Prepack (7) ·
PHOENIX RX LLC (7) ·
Advanced Rx of Tennessee, LLC (5) ·
Amneal Pharmaceuticals LLC (5) ·
Asclemed USA, Inc. (4)
· +22 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.